abemaciclib
eli lilly
['bcsm', 'abema', 'monarche,(-monarcher)', 'abemaciclib', 'monarche']
monarche subgroup analysis: adjuvant abemaciclib efficacy &amp; safety by age. pts &gt;/= 65yo: derived similar benefit from abema as overall population. similar rates of toxicities. idfs similar even if dose modification. qol preserved during treatment. #asco23 #bcsm 
Medical oncologist @Intermountain, Director of Breast Oncology. Clinical research, quality improvement, cardio-oncology, provider wellness. All tweets my own.